These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 9101748)

  • 1. [Prophylaxis secondary to retinitis by CMV in patients with AIDS: the efficacy of an intermittent schedule of 3 days/week].
    Mallolas J; Gatell JM; Gómez-Sirvent JL; Buira E; Zamora L; Alecrim-Andrade J; Adán A; Morales M; Miró JM; Lonća M; Guelar A; Soriano E
    Enferm Infecc Microbiol Clin; 1997 Feb; 15(2):61-4. PubMed ID: 9101748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral ganciclovir for cytomegalovirus retinitis in patients with AIDS: results of two randomized studies.
    Squires KE
    AIDS; 1996 Dec; 10 Suppl 4():S13-8. PubMed ID: 9110065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of CMV retinitis with intravitreal foscarnet].
    Cochereau I; Belayachi N; Diraison C; Matheron S; Bouyer I; Hoang-Xuan T; Saimot AG; Coulaud JP
    J Fr Ophtalmol; 1998 Dec; 21(10):723-6. PubMed ID: 10052044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
    Arch Ophthalmol; 1996 Jan; 114(1):23-33. PubMed ID: 8540847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [High-dose intravitreal ganciclovir in CMV retinitis].
    Cochereau I; Diraison MC; Mousalatti H; Bouyer I; Ren L; Guvenisik N; Hoang-Xuan T
    J Fr Ophtalmol; 2000 Feb; 23(2):123-6. PubMed ID: 10705113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy with a combination of intravitreal foscarnet and intravenous ganciclovir in clinically resistant cytomegalovirus retinitis and patients with acquired immunodeficiency syndrome.
    Guembel HO; Hofmann F; van Even G; Cinatl J; Makabe R
    Ger J Ophthalmol; 1996 Nov; 5(6):490-1. PubMed ID: 9479542
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytomegalovirus retinitis in AIDS patients: a comparative study of intravenous and oral ganciclovir as maintenance therapy.
    Danner SA; Matheron S
    AIDS; 1996 Dec; 10 Suppl 4():S7-11. PubMed ID: 9110064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ganciclovir implants: one year later.
    Cadman J
    GMHC Treat Issues; 1997; 11(4/5):3-6. PubMed ID: 11364375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Digestive cytomegalovirus disease in AIDS patients].
    Barberá JR; Capdevila JA; García-Quintana AM; Calicó I; Allende H; Ruiz I; Ocaña I; Pahissa A
    Enferm Infecc Microbiol Clin; 1996; 14(7):411-5. PubMed ID: 8991434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir.
    Jabs DA
    Infect Agents Dis; 1995 Sep; 4(3):131-42. PubMed ID: 8548191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of cytomegalovirus esophagitis in patients with acquired immune deficiency syndrome: a randomized controlled study of foscarnet versus ganciclovir. The Italian Cytomegalovirus Study Group.
    Parente F; Bianchi Porro G
    Am J Gastroenterol; 1998 Mar; 93(3):317-22. PubMed ID: 9517631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous versus oral ganciclovir: European/Australian comparative study of efficacy and safety in the prevention of cytomegalovirus retinitis recurrence in patients with AIDS. The Oral Ganciclovir European and Australian Cooperative Study Group.
    AIDS; 1995 May; 9(5):471-7. PubMed ID: 7639972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of cytomegalovirus retinitis in AIDS patients with intravitreal ganciclovir.
    Ausayakhun S; Yuvaves P; Ngamtiphakom S; Prasitsilp J
    J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S15-20. PubMed ID: 16681046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New treatment options for CMV retinitis in AIDS.
    Lalezari JP
    Adv Nurse Pract; 1997 Apr; 5(4):45-9, 83. PubMed ID: 9459896
    [No Abstract]   [Full Text] [Related]  

  • 15. Ganciclovir evaluation in AIDS patients with cytomegalovirus retinitis: a European study of treatment patterns and resource utilization.
    Hardens M
    AIDS; 1996 Dec; 10 Suppl 4():S25-30. PubMed ID: 9110067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphonoformate for CMV retinitis in AIDS.
    Colucciello M
    Am J Med; 1995 Mar; 98(3):317-8. PubMed ID: 7872354
    [No Abstract]   [Full Text] [Related]  

  • 17. A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients.
    Shereck EB; Cooney E; van de Ven C; Della-Lotta P; Cairo MS
    Pediatr Blood Cancer; 2007 Sep; 49(3):306-12. PubMed ID: 16972242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytomegalovirus retinitis].
    Usui N; Usui M
    Nihon Rinsho; 1998 Jan; 56(1):197-202. PubMed ID: 9465690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis.
    Walton RC; Whitcup SM; Mueller BU; Lewis LL; Pizzo PA; Nussenblatt RB
    Ophthalmology; 1995 Dec; 102(12):1865-70. PubMed ID: 9098289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraocular therapy for cytomegalovirus retinitis.
    Palestine AG
    J Int Assoc Physicians AIDS Care; 1996 May; 2(5):25-8. PubMed ID: 11363527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.